Scott Wilkinson Net Worth

The estimated Net Worth of Scott Wilkinson is at least $9.46 million dollars as of 1 August 2018. Mr. Wilkinson owns over 17,188 units of Inogen Inc stock worth over $481,636 and over the last 11 years he sold INGN stock worth over $6,461,670. In addition, he makes $2,520,530 as President, Chief Executive Officer et Director at Inogen Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Wilkinson INGN stock SEC Form 4 insiders trading

Scott has made over 21 trades of the Inogen Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 17,188 units of INGN stock worth $662,426 on 1 August 2018.

The largest trade he's ever made was selling 39,344 units of Inogen Inc stock on 1 March 2017 worth over $2,913,817. On average, Scott trades about 8,543 units every 36 days since 2014. As of 1 August 2018 he still owns at least 41,664 units of Inogen Inc stock.

You can see the complete history of Mr. Wilkinson stock trades at the bottom of the page.

Scott Wilkinson biography

Scott Wilkinson is President, Chief Executive Officer, Director of the Company. Previously, he served as our President and Chief Operating Officer from January 1, 2016 through February 28, 2017, and our Executive Vice President, Sales and Marketing from 2008 through December 31, 2015, and in this role, he oversaw Inogen’s global operations in sales, marketing, customer service, product management, medical billing, and clinical services. Prior to that, he served as our Director of Product Management from 2005 to 2006 and Vice President, Product Management from 2006 to 2008. From 2000 to 2005, Mr. Wilkinson worked for Invacare Corporation, a designer and manufacturer of oxygen products, as a Group Product Manager and helped launch their $100 million oxygen product line segment. From 1999 to 2000, Mr. Wilkinson served as a Product Line Director with Johnson & Johnson, a healthcare company. From 1988 to 1999, Mr. Wilkinson worked as a Research Scientist, Product Manager, and Project Leader at Kimberly Clark, a consumer products company. Mr. Wilkinson received a Bachelor of Science degree in Chemical Engineering from the University of Akron and an M.B.A. from University of Wisconsin, Oshkosh. The Board believes that he is qualified to serve as a director of Inogen due to his considerable knowledge and understanding of our business together with his extensive industry experience.

What is the salary of Scott Wilkinson?

As the President, Chief Executive Officer et Director of Inogen Inc, the total compensation of Scott Wilkinson at Inogen Inc is $2,520,530. There are no executives at Inogen Inc getting paid more.

How old is Scott Wilkinson?

Scott Wilkinson is 55, he's been the President, Chief Executive Officer et Director of Inogen Inc since 2017. There are 7 older and 11 younger executives at Inogen Inc. The oldest executive at Inogen Inc is Benjamin Anderson-Ray, 65, who is the Independent Director.

What's Scott Wilkinson's mailing address?

Scott's mailing address filed with the SEC is C/O INOGEN, INC., 326 BOLLAY DRIVE, GOLETA, CA, 93117.

Insiders trading at Inogen Inc

Over the last 11 years, insiders at Inogen Inc have traded over $242,179,025 worth of Inogen Inc stock and bought 9,125 units worth $253,950 . The most active insiders traders include Holdings A/S Novo, Timothy Petersen et Raymond Huggenberger. On average, Inogen Inc executives and independent directors trade stock every 10 days with the average trade being worth of $321,391. The most recent stock trade was executed by Jason Somer on 1 June 2024, trading 577 units of INGN stock currently worth $6,670.

What does Inogen Inc do?

inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when mae, a beloved grandmother, was prescribed oxygen therapy. learn more about mae’s story here: http://www.inogen.com/about-inogen/meet-mae/. inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. we estimate that more than 2.5 million patients in the united states and more than 4.5 million patients worldwide use oxygen therapy. our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. we believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. with each step we take to improve our products and service, our customers take

Complete history of Mr. Wilkinson stock trades at Inogen Inc

Inogen Inc executives and stock owners

Inogen Inc executives and other stock owners filed with the SEC include:

• Scott Wilkinson,
  President, Chief Executive Officer, Director
• Alison Bauerlein,
  Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate Treasurer
• Bart Sanford,
  Executive Vice President, Operations
• Byron Myers,
  Executive Vice President of Marketing
• Brenton Taylor,
  Executive Vice President - Engineering
• Dr. Stanislav Glezer M.D., MBA,
  Exec. VP & CTO
• Alison Perry Bauerlein,
  Co-Founder
• Bart Sanford,
  Exec. VP of Operations
• Heath Lukatch,
  Independent Chairman of the Board
• Heather Rider,
  Independent Director
• R. Scott Greer,
  Independent Director
• Loren McFarland,
  Independent Director
• Benjamin Anderson-Ray,
  Independent Director
• Raymond Huggenberger,
  Independent Director
• Matt Bacso,
  IR Contact Officer
• Scott Beardsley,
  Independent Director
• Arron Retterer,
  Executive Vice President of Sales
• Jennifer Yi Boyer,
  Exec. VP & Chief HR Officer
• Agnes Lee,
  Sr. VP of Investor Relations & Strategic Planning
• Kristin A. Caltrider,
  Exec. VP, CFO & Treasurer
• Matthew Pigeon,
  Investor Relations Officer
• George J. Parr,
  Exec. VP & Chief Commercial Officer
• Jason Somer,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Matthew James Bacso C.F.A.,
  Investor Relations & Corp. Devel. Mang.
• Michael K. Sergesketter,
  Interim Chief Financial Officer
• Nabil Shabshab,
  CEO, Pres & Director
• Kevin M King,
  
• Matt Scribner,
  See Remarks
• George J Parr,
  Chief Commercial Officer
• William J Phd Link,
  Director
• Ventures Ii Llc Versant Ven...,
  
• Kristin A. Caltrider,
  EVP, CFO and Treasurer
• Ventures Ii Llc Versant Ven...,
  
• Ventures Ii Llclink William...,
  
• Ventures Ii Lp Arboretum Ve...,
  
• Stephen E. Cooper,
  Director
• Ventures Ii Llc Versant Ven...,
  
• Ventures Ii Llc Versant Ven...,
  
• Ventures Ii Llc Versant Ven...,
  
• Holdings A/S Novo,
  10% owner
• Charles E Larsen,
  Director
• Timothy Petersen,
  Director
• Ventures Ii Llc Versant Ven...,
  
• Kevin Raymond Merrill Smith,
  CEO and President
• Kristen Miranda,
  Director
• Nabil Shabshab,
  CEO and President
• Stanislav Glezer,
  EVP, R&D & Chief Med. Officer
• Jason Somer,
  EVP, Gen. Counsel & Secretary
• Michael J. Bourque,
  EVP, CFO & Treasurer
• Elizabeth Mora,
  
• Thomas A. West,
  
• Mary Kay Ladone,
  
• Glenn S Boehnlein,
  
• Kevin P. Smith,
  EVP, Bus Dev, GC & Sec